Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
ipo
6
×
life sciences
national blog main
sanofi
6
×
boston top stories
clinical trials
national top stories
san francisco blog main
san francisco top stories
new york blog main
new york top stories
boulder/denver blog main
boulder/denver top stories
cancer drugs
deals
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
investing
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
takeda pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
allergan
alzheimer's disease
What
ipo
medicines
bio
roundup
cancer
companies
drug
pharmaceutical
proteins
research
revolution
acquisitions
alzheimer’s
announced
black
cancer’s
ceo
collabs
company’s
continue
course
covid
daniel
deal
debut
despite
development
diamond
diamond’s
different
discover
disease
experimental
fail
family
frontiers
gene
gilead
gilead’s
growing
Language
unset
Current search:
sanofi
×
ipo
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More